BCL2 and diffuse large B-cell lymphoma: High levels of BCL-2 were also detected in several other haematological malignancies, including chronic lymphocytic leukemia (CLL), diffuse large B cell lymphoma (DLBCL) and mantle cell lymphoma [138–140] and in certain solid tumours, including subsets of brain, breast and lung cancer [141, 142].